Similar articles

• Gastrointestinal stromal tumors: current management.

  Pisters PW, Patel SR. Pisters PW, et al. J Surg Oncol. 2010 Oct 1;102(5):530-8. doi: 10.1002/jso.21460. J Surg Oncol. 2010. PMID: 20063363 Review.
• Hits and misses in targeting pediatric cancers.

  Bernstein ML. Bernstein ML. Pediatr Blood Cancer. 2009 Jul;52(7):751-2. doi: 10.1002/pbc.21937. Pediatr Blood Cancer. 2009. PMID: 19185009 No abstract available.
• [Consensus on the medical treatment of gastrointestinal stromal tumors].

  [No authors listed] [No authors listed] Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):875-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396652 Chinese. No abstract available.
• Controversies in the surgical management of GIST in the era of imatinib.

  Raut CP, Bertagnolli MM. Raut CP, et al. Oncology (Williston Park). 2009 Jan;23(1):69, 74-6. Oncology (Williston Park). 2009. PMID: 19283924
• Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?

  von Mehren M, Watson JC. von Mehren M, et al. Oncology (Williston Park). 2009 Jan;23(1):65-6. Oncology (Williston Park). 2009. PMID: 19283923 Free PMC article. No abstract available.